Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/CGEN stock hub

TLV/CGEN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/CGENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

794.9M

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/CGEN

In the news

Latest news · TLV/CGEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E7.1

P25 n/aP50 n/aP75 n/a

ROE44.8

P25 n/aP50 n/aP75 n/a

ROIC23.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/CGEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	75
Employees Change	6%
Employees Change Percent	8.82
Enterprise value	ILA 381.3M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	IL0010852080
Last refreshed	2026-05-10
Market cap	ILA 794.9M
Price	ILA 834
Price currency	ILA
Rev Per Employee	3,092,955.09x
Sector	Healthcare
Sic	2836
Symbol	tlv/CGEN
Website	https://cgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	14.17%
EV Earnings	3.38x
EV/EBIT	4.2x
EV/EBITDA	4.04x
EV/FCF	3.82x
EV/Sales	1.81x
FCF yield	12.56%
P/B ratio	2.43x
P/E ratio	7.06x
P/S ratio	3.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	43.05%
EBITDA Margin	43.7%
FCF margin	43.05%
Gross margin	87.29%
Gross Profit	ILA 202.5M
Gross Profit Growth	218.62%
Gross Profit Growth Q	7,914.57%
Gross Profit Growth3 Y	113.51%
Gross Profit Growth5 Y	100.91%
Net Income	ILA 112.7M
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Pretax Margin	48.65%
Profit Margin	48.57%
Profit Per Employee	ILA 1.5M
Profitable Years	1
ROA	14.42
Roa5y	-7.35
ROCE	23.38
ROE	44.84
Roe5y	-14.35
ROIC	23.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.43%
Cagr15y	-4.18%
Cagr1y	82.06%
Cagr20y	-3.6%
Cagr3y	53.99%
Cagr5y	-19.72%
EPS Growth Quarters	1
EPS Growth Years	4
FCF Growth	-36.69%
OCF Growth	-36.23%
Revenue Growth	161.14x
Revenue Growth Q	4,477.29x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	113.28x
Revenue Growth5 Y	105.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.54
Assets	ILA 499.1M
Cash	ILA 464.3M
Current Assets	ILA 429.4M
Current Liabilities	ILA 65.5M
Debt	ILA 9.4M
Debt EBITDA	ILA 0.09
Debt Equity	ILA 0.03
Debt FCF	ILA 0.09
Equity	ILA 327.5M
Liabilities	ILA 171.6M
Long Term Assets	ILA 69.7M
Long Term Liabilities	ILA 106.2M
Net Cash	ILA 454.9M
Net Cash By Market Cap	ILA 57.22
Net Cash Growth	42.19%
Net Debt EBITDA	ILA -4.49
Net Debt Equity	ILA -1.39
Net Debt FCF	ILA -4.55
Tangible Book Value	ILA 327.5M
Tangible Book Value Per Share	ILA 3.46
WACC	19.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.56
Net Working Capital	ILA -62.7M
Quick ratio	6.46
Working Capital	ILA 399.9M
Working Capital Turnover	ILA 2.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-66.76%
1Y total return	81.98%
200-day SMA	574.7
3Y total return	265.24%
50-day SMA	711.4
50-day SMA vs 200-day SMA	50over200
5Y total return	-66.66%
All Time High	6,766
All Time High Change	-87.67%
All Time High Date	2020-08-26
All Time Low	160.4
All Time Low Change	420.07%
All Time Low Date	2008-12-15
ATR	44.18
Beta	2.8
Ch YTD	78.25
High	847.8
High52	924
High52 Date	2026-04-27
High52ch	-9.72%
Low	807
Low52	435
Low52 Date	2025-09-21
Low52ch	91.77%
Ma50ch	17.25%
Price vs 200-day SMA	45.15%
RSI	58.04
RSI Monthly	58.62
RSI Weekly	41.33
Sharpe ratio	0.98x
Sortino ratio	1.83
Total Return	-4.79%
Tr YTD	78.25
Tr15y	-47.34%
Tr1m	19.21%
Tr1w	9.29%
Tr3m	60.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA 99.9M
Operating margin	43.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	92,414,057%
Shares Insiders	0.32%
Shares Institutions	13.6%
Shares Qo Q	0.82%
Shares Yo Y	4.79%
Short Ratio	2.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 93.9M
Average Volume	69,226.85x
Bv Per Share	3.46
CAPEX	ILA -975,528
Ch10y	-66.76
Ch15y	-47.34
Ch1m	19.21
Ch1w	9.29
Ch1y	81.98
Ch20y	-51.92
Ch3m	60.61
Ch3y	265.2
Ch5y	-66.66
Ch6m	60.42
Change	-0.13%
Change From Open	-0.13
Close	835.3
Days Gap	0
Depreciation Amortization	1,377,975
Dollar Volume	16,333,636
Earnings Date	2026-05-18
EBIT	ILA 99.9M
EBITDA	ILA 101.4M
EPS	ILA 1.21
F Score	6
FCF	ILA 99.9M
FCF EV Yield	26.19x
Financing CF	33,805,552
Fiscal Year End	December
Founded	1,993
Graham Number	956.21493
Graham Upside	14.63
Income Tax	ILA 172,152
Investing CF	95,624,060
Is Primary Listing	0
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Ma150	600
Ma150ch	39.03%
Ma20	817.2
Ma20ch	2.08%
Net CF	230,709,184
Next Earnings Date	2026-05-18
Open	835.3
P FCF Ratio	7.96
P OCF Ratio	7.88
Position In Range	66.67
Ppne	9,289,002
Price Date	2026-05-08
Price EBITDA	ILA 7.84
Ptbv Ratio	2.43
Relative Volume	0.28x
Revenue	231,971,632x
SBC By Revenue	2.59x
Share Based Comp	5,996,628
Tax By Revenue	0.07x
Tax Rate	0.15%
Tr20y	-51.92%
Tr6m	60.42%
Volume	19,580
Z Score	-0.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/CGEN pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/CGEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/CGEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.6%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TLV/CGEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.0

Neutral momentum band

Price vs 200-day MA

+45.2%

50/200-day relationship not available

Beta (5Y)

2.80

More volatile than the market

Sharpe ratio

0.98

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/CGEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/CGEN stock rating?

tlv/CGEN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/CGEN analysis?

The full report lives at /stocks/tlv/CGEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/CGEN?

The latest report frames tlv/CGEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/CGEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.